FDA Approvals

Nubeqa Now Indicated for Metastatic Hormone-Sensitive Prostate Cancer

Imfinzi Receives New FDA Indication for Advanced or Metastatic Biliary Tract Cancer

Retevmo Receives New FDA Indication for Advanced Solid Tumors with RET Fusion

Imbruvica Now Also Indicated for Children with Chronic Graft-versus-Host Disease

Pemazyre Receives New Indication for FGFR1-Positive Myeloid/Lymphoid Neoplasms

Vegzelma a New Biosimilar FDA Approved for the Treatment of 6 Types of Cancer

Enhertu First FDA-Approved Drug for HER2-Positive Non–Small-Cell Lung Cancer

Enhertu First FDA-Approved Treatment for HER2-Low Breast Cancer

Lytgobi FDA Approved for Intrahepatic Cholangiocarcinoma with FGFR2 Fusion

Breyanzi Now FDA Approved for Second-Line Treatment of Large B-Cell Lymphoma

1
2
3
4

Page 1 of 26
Results 1 - 10 of 256

SUBSCRIBE

© Amplity Health. All rights reserved.

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

AHDB Print Edition

AHDB Weekly e‑Newsletter

I have reviewed and consent to the terms of AHDB's Privacy Policy, and AHDB has my permission to retain my information in its database, and to forward pertinent communications to me.